IGM Biosciences, Inc. (IGMS) Operating Income (Loss) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IGM Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • IGM Biosciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$53.9 M, a 15% increase year-over-year.
  • IGM Biosciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$254 M, a 6.09% decline year-over-year.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$263 M, a 15.6% decline from 2022.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$228 M, a 37.9% decline from 2021.
  • IGM Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$165 M, a 98.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$254 M -$53.9 M +$9.52 M +15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$263 M -$65.1 M -$8.86 M -15.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$255 M -$66.8 M -$6.25 M -10.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$248 M -$68.2 M -$8.98 M -15.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$239 M -$63.4 M -$11.4 M -22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$228 M -$56.3 M -$5.58 M -11% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$222 M -$60.5 M -$16.3 M -36.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$206 M -$59.2 M -$20.5 M -52.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$186 M -$52 M -$20.3 M -63.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$165 M -$50.7 M -$25.9 M -105% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 -$139 M -$44.2 M -$23.6 M -115% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$116 M -$38.7 M -$19.3 M -99.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$96.4 M -$31.7 M -$13.1 M -70.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$83.3 M -$24.7 M -$8.8 M -55.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-30
Q3 2020 -$74.5 M -$20.6 M -$9.89 M -92.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$64.6 M -$19.4 M -$8.88 M -84.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$55.7 M -$18.6 M -$11.2 M -152% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$44.5 M -$15.9 M -$6.89 M -76.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$37.6 M -$10.7 M -$4.13 M -63.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-30
Q2 2019 -$33.5 M -$10.5 M -$6.29 M -148% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-30
Q1 2019 -$27.2 M -$7.36 M -$4.4 M -149% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-30
Q4 2018 -$22.8 M -$9.05 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$6.55 M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-26
Q2 2018 -$4.24 M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-26
Q1 2018 -$2.96 M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.